PHÂN TÍCH TÁC ĐỘNG NGÂN SÁCH TRONG ĐIỀU TRỊ CÁC BỆNH NỘI TIẾT, DINH DƯỠNG, VÀ CHUYỂN HÓA: NGHIÊN CỨU TẠI BỆNH VIỆN LÊ VĂN THỊNH

Abstract

Objective: This study aims to analyze the budget impact of treating endocrine, nutritional, and metabolic diseases (ENMD) at Le Van Thinh Hospital (LVTH) during the period from 2018 to 2023. Subjects and Methods: This is a cross-sectional descriptive study conducted by retrospectively collecting data on direct medical costs for treating ENMD, classified under ICD-10 codes E00-E90, for all patients with health insurance at LVTH from 2018 to 2023. The budget impact was assessed through the total healthcare expenditure for patients each year, categorized by source of payment, disease group, treatment scope, and cost components. Results: From 2018 to 2023, a total of VND 202.127 billion was spent on direct medical costs for treating ENMD patients with health insurance at LVTH, with 84.4% of these costs covered by health insurance. Outpatient treatments accounted for 92.3% of the total costs. The two disease groups with the highest total costs were diabetes (80.9% of total costs) and metabolic disorders (13.4% of total costs). The average cost per outpatient visit was VND 573,276, and the average cost per inpatient stay was VND 5,272,142, showing a trend of increasing costs over time. Conclusion: This study provides comprehensive information on the budget impact and cost allocation trends for treating ENMD at LVTH over an extended period, encompassing pre-, during, and post-Covid-19 phases. The findings contribute valuable data for resource allocation and budget adjustment decisions at LVTH.